Assay of factor VIII concentrates: comparison of the chromogenic and two-stage clotting assaysHUBBARD, A. R; CURTIS, A. D; BARROWCLIFFE, T. W et al.Thrombosis research. 1986, Vol 44, Num 6, pp 887-891, issn 0049-3848Article

Screening of factor VIII:C levels in blood donorsCARLEBJORK, G; BLOMBACK, M; BLOMSTEDT, M et al.Vox sanguinis (Basel. 1956). 1986, Vol 51, Num 4, pp 306-309, issn 0042-9007Article

Severe factor VIII deficiency in a chromosomally normal femaleSTORMORKEN, H; HESSEL, B; LUNDE, J et al.Thrombosis research. 1986, Vol 44, Num 1, pp 113-117, issn 0049-3848Article

The influence of D.D.A.V.P. on the survival of factor VIII in severe haemophiliacsMCLELLAN, D. S; KNIGHT, S; MCLELLAN, H. G et al.Thrombosis research. 1985, Vol 40, Num 1, pp 113-119, issn 0049-3848Article

Factor VIII activity as measured by an amidolytic assay compared with a one-stage clotting assayTRIPODI, A; MANNUCCIO MANNUCCI, P.American journal of clinical pathology. 1986, Vol 86, Num 3, pp 341-344, issn 0002-9173Article

Degradation of factor VIII coagulant antigen by proteolytic enzymesRICK, M. E; POPOVSKY, M. A; KRIZEK, D. M et al.British journal of haematology. 1985, Vol 61, Num 3, pp 477-486, issn 0007-1048Article

Use of plasma segments for estimating factor VIII activity in pools of fresh frozen plasmaOFOSU, F. A; SMITH, L. M; BLAJCHMAN, M. A et al.Vox sanguinis (Basel. 1956). 1987, Vol 52, Num 3, pp 254-256, issn 0042-9007Article

The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIIIGRIFFIN, B. D; MICKLEM, L. R; MCCANN, M. C et al.Thrombosis and haemostasis. 1986, Vol 55, Num 1, pp 40-46, issn 0340-6245Article

Factor VIII lability, protein C and other vitamin K-dependent proteinsTAKAHASHI, H; HANANO, M; TATEWAKI, W et al.Thrombosis research. 1986, Vol 43, Num 5, pp 561-568, issn 0049-3848Article

Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitateDE WIT, H. J. C; SCHEER, G; MURADIN, J et al.Vox sanguinis (Basel. 1956). 1986, Vol 51, Num 3, pp 172-175, issn 0042-9007Article

A component of factor VIII preparations which can be separated from factor VIII activity down modulates human monocyte functionsEIBL, M. M; AHMAD, R; WOLF, H. M et al.Blood. 1987, Vol 69, Num 4, pp 1153-1160, issn 0006-4971Article

Pasteurization as an efficient method to inactivate blood borne viruses in factor VIII concentrationsHILFENHAUS, J; WEIDMANN, E.Arzneimittel-Forschung. 1986, Vol 36, Num 4, pp 621-625, issn 0004-4172Article

Antihemophilic factor (factor VIII) preparations inhibit lymphocyte proliferation and production of interleukin-2LEDERMAN, M. M; SAUNDERS, C; TOOSSI, Z et al.The Journal of laboratory and clinical medicine. 1986, Vol 107, Num 5, pp 471-478, issn 0022-2143Article

Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodiesHORNSEY, V; MICKLEM, L. R; MCCANN, M. C et al.Thrombosis and haemostasis. 1985, Vol 54, Num 2, pp 510-514, issn 0340-6245Article

Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assaysHORNSEY, V; WATERSTON, Y. G; PROWSE, C. V et al.Journal of clinical pathology. 1988, Vol 41, Num 5, pp 562-567, issn 0021-9746Article

Studies on the stability of VIII-C during the manufacture of a factor VIII concentrate for clinical useFOSTER, P. R; DICKSON, I. H; MCQUILLAN, T. A et al.Vox sanguinis (Basel. 1956). 1988, Vol 55, Num 2, pp 81-89, issn 0042-9007Article

Immunoadsorption of factor VIII inhibitorsFREEDMAN, John; GARVEY, M. Bernadette.Current opinion in hematology. 2004, Vol 11, Num 5, pp 327-333, issn 1065-6251, 7 p.Article

Increased factor VIII/vWf levels in patients with reduced platelet numberCASONATO, A; FABRIS, F; BOSCARO, M et al.Blut. 1987, Vol 54, Num 5, pp 281-288, issn 0006-5242Article

Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors)HOYER, L. W.Human pathology. 1987, Vol 18, Num 2, pp 153-161, issn 0046-8177Article

Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipidsROBERTS, D. D; NAGESWARA RAO, C; LIOTTA, L. A et al.The Journal of biological chemistry (Print). 1986, Vol 261, Num 15, pp 6872-6877, issn 0021-9258Article

Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factorPARKER, R. I; GRALNICK, H. R.Blood. 1986, Vol 68, Num 3, pp 732-736, issn 0006-4971Article

Mechanism of factor VIII inactivation by human antibodies. IV: Antibody binding prevents factor VIII proteolysis by thrombinLAZARCHICK, J; ASHBY, M. A; LAZARCHICK, J. J et al.Annals of clinical and laboratory science. 1986, Vol 16, Num 6, pp 497-501, issn 0091-7370Article

Clinical application of a chromogenic substrate method for determination of factor VIII activityROSEN, S; ANDERSSON, M; VINAZZER, H et al.Thrombosis and haemostasis. 1985, Vol 54, Num 4, pp 818-823, issn 0340-6245Article

Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesHELDEBRANT, C. M; GOMPERTS, E. D; LAM, W et al.Transfusion (Philadelphia, PA). 1985, Vol 25, Num 6, pp 510-515, issn 0041-1132Article

The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIIIMERTENS, K; VAN WIJNGAARDEN, A; BERTINA, R. M et al.Thrombosis and haemostasis. 1985, Vol 54, Num 3, pp 650-653, issn 0340-6245Article